CCL2 and glioblastoma: To evaluate whether CCL2 has prognostic value in GBM patients, high-throughput RNA sequencing data and corresponding survival status of GBM patients were downloaded from the TCGA database (https://portal.gdc.cancer.gov/), which manifested that high CCL2 expression was a risk factor (Fig. 3A-C).